Meetings: National Heart, Lung, and Blood Institute,
[Federal Register: April 8, 1998 (Volume 63, Number 67)]
[Notices]
[Page 17192]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08ap98-99]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Closed Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following National Heart, Lung, and Blood Institute meetings:
Name of Committee: Clinical Trials Review Committee.
Date: June 21-23, 1998.
Time: 7:00 p.m.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, Maryland 20814.
Contact Person: Joyce A. Hunter, Ph.D., Two Rockledge Center, Room 7192, 7601 Rockledge Drive, Bethesda, Maryland 20982-7924, (301) 435-0287.
Purpose/Agenda: To review and evaluate Clinical Trial and R03 grant applications.
Name of Committee: National Heart, Lung, and Blood Special Emphasis Panel (A Related Umbilical Cord Blood Bank for Hemoglobinopathy Patients)--Telephone Conference Call.
Date: May 11, 1998.
Time: 2:00 p.m.
Place: Rockledge Center II, Room 7214, 6701 Rockledge Drive, Bethesda, Maryland 20892-7924.
Contact Person: Camille King, Ph.D., Two Rockledge Center, Room 7208A, 6701 Rockledge Drive, Bethesda, Maryland 20892-7924, (301) 435-0321.
Purpose/Agenda: To review and evaluate grant applications.
Name of Committee: National Heart, Lung, and Blood Special Emphasis Panel (Immunogenetics of Inhibitor Formation in Hemophilia.
Date: June 15, 1998.
Time: 8:00 a.m.
Place: Holiday Inn Silver Spring, 8777 Georgia Avenue, Silver Spring, Maryland 20910.
Contact Person: Deborah Beebe, Ph.D., Two Rockledge Center, Room 7178, 6701 Rockledge Drive, Bethesda, Maryland 20892-7924, (301) 435-0270.
Purpose/Agenda: To review and evaluate grant applications.
These meetings will be closed in accordance with the provisions set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications and/or proposals and the discussions could reveal confidential trade secrets or commercial property such as patentable material and personal information concerning individuals associated with the applications and/or proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; and 93.839, Blood Diseases and Resources Research, National Institutes of Health.)
Dated: April 2, 1998. LaVerne Y. Stringfield, Committee Management Officer, NIH.
[FR Doc. 98-9226Filed4-7-98; 8:45 am]
BILLING CODE 4140-01-M
